Mesplede T - Search Results

1

HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy.

Wijting IEA, Lungu C, Rijnders BJA, van der Ende ME, Pham HT, Mesplede T, Pas SD, Voermans JJC, Schuurman R, van de Vijver DAMC, Boers PHM, Gruters RA, Boucher CAB, van Kampen JJA. Wijting IEA, et al. Among authors: mesplede t. J Infect Dis. 2018 Jul 24;218(5):688-697. doi: 10.1093/infdis/jiy176. J Infect Dis. 2018. PMID: 29617822

2

Characterization of the R263K mutation in HIV-1 integrase that confers low-level resistance to the second-generation integrase strand transfer inhibitor dolutegravir.

Quashie PK, Mesplède T, Han YS, Oliveira M, Singhroy DN, Fujiwara T, Underwood MR, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. J Virol. 2012 Mar;86(5):2696-705. doi: 10.1128/JVI.06591-11. Epub 2011 Dec 28. J Virol. 2012. PMID: 22205735 Free PMC article.

3

A high-throughput assay for HIV-1 integrase 3'-processing activity using time-resolved fluorescence.

Han YS, Quashie P, Mesplede T, Xu H, Mekhssian K, Fenwick C, Wainberg MA. Han YS, et al. Among authors: mesplede t. J Virol Methods. 2012 Sep;184(1-2):34-40. doi: 10.1016/j.jviromet.2012.05.003. Epub 2012 May 11. J Virol Methods. 2012. PMID: 22584270

4

Resistance to HIV integrase inhibitors.

Mesplède T, Quashie PK, Wainberg MA. Mesplède T, et al. Curr Opin HIV AIDS. 2012 Sep;7(5):401-8. doi: 10.1097/COH.0b013e328356db89. Curr Opin HIV AIDS. 2012. PMID: 22789986 Review.

5

The development of novel HIV integrase inhibitors and the problem of drug resistance.

Wainberg MA, Mesplède T, Quashie PK. Wainberg MA, et al. Among authors: mesplede t. Curr Opin Virol. 2012 Oct;2(5):656-62. doi: 10.1016/j.coviro.2012.08.007. Epub 2012 Sep 16. Curr Opin Virol. 2012. PMID: 22989757 Review.

6

HIV Drug Resistance and the Advent of Integrase Inhibitors.

Quashie PK, Mesplède T, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. Curr Infect Dis Rep. 2013 Feb;15(1):85-100. doi: 10.1007/s11908-012-0305-1. Curr Infect Dis Rep. 2013. PMID: 23180144

7

Evolution of HIV integrase resistance mutations.

Quashie PK, Mesplède T, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. Curr Opin Infect Dis. 2013 Feb;26(1):43-9. doi: 10.1097/QCO.0b013e32835ba81c. Curr Opin Infect Dis. 2013. PMID: 23242340 Review.

8

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure.

Mesplède T, Quashie PK, Osman N, Han Y, Singhroy DN, Lie Y, Petropoulos CJ, Huang W, Wainberg MA. Mesplède T, et al. Retrovirology. 2013 Feb 22;10:22. doi: 10.1186/1742-4690-10-22. Retrovirology. 2013. PMID: 23432922 Free PMC article.

9

Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors.

Han YS, Xiao WL, Quashie PK, Mesplède T, Xu H, Deprez E, Delelis O, Pu JX, Sun HD, Wainberg MA. Han YS, et al. Among authors: mesplede t. Antiviral Res. 2013 Jun;98(3):441-8. doi: 10.1016/j.antiviral.2013.04.001. Epub 2013 Apr 9. Antiviral Res. 2013. PMID: 23583286

10

Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase.

Quashie PK, Mesplède T, Han YS, Veres T, Osman N, Hassounah S, Sloan RD, Xu HT, Wainberg MA. Quashie PK, et al. Among authors: mesplede t. Antimicrob Agents Chemother. 2013 Dec;57(12):6223-35. doi: 10.1128/AAC.01835-13. Epub 2013 Sep 30. Antimicrob Agents Chemother. 2013. PMID: 24080645 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters